Fasting-mimicking diet with immunotherapy for advanced lung cancer
Part of Cancer, Lungs & breathing clinical trials.
This study combines a special periodic diet that mimics fasting with the standard immunotherapy drug pembrolizumab (Keytruda) for people with advanced non-small cell lung cancer. The goal is to see if the diet can help the immunotherapy work better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have stage IV non-small cell lung cancer (advanced, has spread) and plan to start standard immunotherapy (pembrolizumab alone)
- Your body mass index (BMI) is at least 19
- You have not lost more than 10% of your body weight in the past 6 weeks
- You do not have diabetes or a history of low blood sugar
- You are not taking immune-suppressing drugs (like high-dose steroids or transplant medications)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial adds a fasting-mimicking diet to standard chemotherapy before surgery for a specific type of breast cancer. The diet may help make the chemotherapy work better while reducing side effects.
This trial tests whether an intermittent, fasting-like diet can help control metastatic prostate cancer and improve metabolic health in men on hormone therapy. Participants follow a specific diet plan and are monitored by the study team.
This trial tests a special low-calorie diet (fasting-mimicking diet) combined with two types of medicine (immunotherapy and targeted therapy) for people with advanced kidney cancer. The diet might help the medicines work better.
This trial studies whether intermittent fasting (eating only during certain hours) can make immunotherapy treatment work better or cause fewer side effects in people with certain advanced cancers. If you can safely fast, this could be a way to boost your treatment.
This trial tests whether a special low-calorie diet (fasting-like) combined with maintenance immunotherapy can help people with extensive-stage small-cell lung cancer live longer without the cancer growing. It is for patients who have already completed initial chemoimmunotherapy and whose cancer has not progressed.
This trial tests whether adding a special low-calorie diet (called a fasting-mimicking diet) to standard chemotherapy and immunotherapy can help treat triple-negative breast cancer before surgery. It aims to see if this combination makes the treatment work better.
Hear when a new Immunotherapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.